Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 80/100

ASX ANNOUNCEMENT 3 December 2025 Results of General Meeting Sydney, Australia - Wednesday, 3 December 2025 - Radiopharm Theranostics Limited (ASX: RAD; Nasdaq: RADX) advises that all resolutions considered at the General

Thursday, December 4, 2025 1 min read
Key Takeaway: Radiopharm Theranostics Limited announced that all resolutions presented at its General Meeting held on December 3, 2025, were approved by poll. The company provided detailed voting results in accordance with ASX Listing Rules, showing significant support for each resolution, including the approval of placement shares and options. This successful outcome reflects the favorable reception of the company's strategies among its shareholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • All resolutions at the General Meeting were approved successfully.
  • High percentage of votes in favor for each resolution, indicating strong support.
  • Transparency in the voting process as detailed results were provided.

Full Press Release Details

Results of General Meeting
Sydney, Australia - Wednesday, 3 December 2025
- Radiopharm Theranostics Limited (ASX: RAD; Nasdaq: RADX) advises that all resolutions considered at the General Meeting
held today were carried by poll.
In accordance with ASX Listing Rule 3.13.2 and Section 251AA(1)
of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.
Joint Company Secretary
Radiopharm Theranostics Limited
Suite 1, Level 3, 62 Lygon Street,
Carlton South VIC 3053 Australia
Disclosure of Proxy Votes
Radiopharm Theranostics Limited Extraordinary General Meeting Wednesday, 03 December 2025 GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814
In accordance with section 251AA of the Corporations Act
2001, the following information is provided in relation to resolutions put to members at the meeting.
Proxy Votes Poll Results (if applicable) Results
Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed FOR AGAINST ABSTAIN PROXY'S DISCRETION FOR AGAINST ABSTAIN OUTCOME
1 Ratification of prior issue of First Tranche Placement Shares to Placement Participants P 310,229,670 297,621,056 95.94% 10,828,904 3.49% 674,119 1,779,710 0.57% 585,859,279 98.19% 10,828,904 1.81% 674,119 Carried
2 Approval to issue Second Tranche Placement Shares P 310,191,235 297,822,621 96.01% 10,588,904 3.41% 762,554 1,779,710 0.57% 303,102,331 96.62% 10,588,904 3.38% 283,721,067 Carried
3 Approval to issue Placement Attaching Options P 310,191,235 294,895,689 95.07% 13,515,836 4.36% 762,554 1,779,710 0.57% 298,675,399 95.21% 15,015,836 4.79% 762,554 Carried
4 Approval to issue SPP Attaching Options P 613,812,137 599,101,316 97.60% 12,931,111 2.11% 276,801 1,779,710 0.29% 883,839,539 98.39% 14,431,111 1.61% 276,801 Carried

Frequently Asked Questions

When was the Radiopharm Theranostics General Meeting held?

The General Meeting took place on Wednesday, 3 December 2025.

How were the resolutions decided at the meeting?

All resolutions were carried by poll.

What was the outcome of the first resolution?

The first resolution was carried with 98.19% voting in favor.

What percentage supported the second resolution?

The second resolution received 96.62% approval.

What is the contact information provided in the meeting?

Contact details include a phone number and email for inquiries.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm General Meeting shareholder approval placement shares
Last updated: Dec 4, 2025